Drug Discovery of COPD


Chronic obstructive pulmonary disease is an increasing worldwide medical issue and cause of death. COPD predominantly influencing small airway routes and lung parenchyma that prompts dynamic aviation route deterrent. COPD is a standout amongst the most widely recognized infections on the globe, and there is a global increase in prevalence, however there are no drugs available at present that halt the relentless progression of this disease. In any case, a superior comprehension of the cell and molecular mechanisms that are associated with the underlying inflammatory and destructive processes has uncovered a few new focuses for which drugs are presently being developed, and the prospects for finding new medications are good.


  • LABA–LAMA
  • Bronchodilators
  • Inhaled corticosteroids

Related Conference of Drug Discovery of COPD

November 22-23, 2021

11th International Conference on COPD and Lungs

Singapore City, Singapore
November 29-29, 2021

2nd International Conference on Lung Diseases

London, UK
March 21-22, 2022

42nd World Conference on Lung Diseases & Pulmonology

Brussels, Belgium

Drug Discovery of COPD Conference Speakers

Recommended Sessions

Related Journals

Are you interested in